{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:16:18Z","timestamp":1792167378987,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["20FC1039"],"award-info":[{"award-number":["20FC1039"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.yebeh.2021.108220","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T20:15:58Z","timestamp":1628280958000},"page":"108220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Effects of l-carnitine supplementation in patients with childhood-onset epilepsy prescribed valproate"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2447-2857","authenticated-orcid":false,"given":"Akihisa","family":"Okumura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Numoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Iwayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5363-5638","authenticated-orcid":false,"given":"Yoshiteru","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Kurahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2021.108220_b0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jat\/20.1.55","article-title":"Valproic acid overdose and L-carnitine therapy","volume":"20","author":"Ishikura","year":"1996","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.yebeh.2021.108220_b0010","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0022-3476(82)80320-X","article-title":"Carnitine deficiency and hyperammonemia associated with valproic acid therapy","volume":"101","author":"Ohtani","year":"1982","journal-title":"J Pediatr"},{"key":"10.1016\/j.yebeh.2021.108220_b0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0887-8994(97)00026-X","article-title":"Diet- and valproate-induced transient hyperammonemia: effect of L-carnitine","volume":"16","author":"Gidal","year":"1997","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2021.108220_b0020","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.braindev.2019.02.010","article-title":"Serum carnitine levels of children with epilepsy: Related factors including valproate","volume":"41","author":"Okumura","year":"2019","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2021.108220_b0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s005990050060","article-title":"Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs","volume":"29","author":"Verrotti","year":"1999","journal-title":"Int J Clin Lab Res"},{"key":"10.1016\/j.yebeh.2021.108220_b0030","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.braindev.2005.11.005","article-title":"Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet","volume":"28","author":"Coppola","year":"2006","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2021.108220_b0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.eplepsyres.2009.04.002","article-title":"The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status","volume":"86","author":"Hamed","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2021.108220_b0040","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1469-8749.1991.tb14963.x","article-title":"Ammonia and carnitine concentrations in children treated with sodium valproate compared with other anticonvulsant drugs","volume":"33","author":"Thom","year":"1991","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2021.108220_b0045","first-page":"999","article-title":"The effect of valproic acid on plasma carnitine levels","volume":"145","author":"Opala","year":"1991","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.yebeh.2021.108220_b0050","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/0883073808321060","article-title":"Serum and muscle carnitine levels in epileptic children receiving sodium valproate","volume":"24","author":"Anil","year":"2009","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2021.108220_b0055","doi-asserted-by":"crossref","first-page":"107883","DOI":"10.1016\/j.yebeh.2021.107883","article-title":"Carnitine supplementation prevents carnitine deficiency caused by pivalate-conjugated antibiotics in patients with epilepsy prescribed valproate","volume":"117","author":"Okumura","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108220_b0060","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108220_b0065","doi-asserted-by":"crossref","unstructured":"Takahashi M, Ueda S, Misaki H, Sugiyama N, Matsumoto K, Matsuo N, et al. Carnitine determination by an enzymatic cycling method with carnitine dehydrogenase. Clin Chem 1994; 40: 817\u201321.","DOI":"10.1093\/clinchem\/40.5.817"},{"key":"10.1016\/j.yebeh.2021.108220_b0070","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/ped.14360","article-title":"A pilot study of serum free carnitine levels in hospitalized febrile children","volume":"63","author":"Okumura","year":"2021","journal-title":"Pediatr Int"},{"key":"10.1016\/j.yebeh.2021.108220_b0075","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.yebeh.2021.108220_b0080","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2174\/1570159X17666181227165722","article-title":"Valproic acid and epilepsy: from molecular mechanisms to clinical evidences","volume":"17","author":"Romoli","year":"2019","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.yebeh.2021.108220_b0085","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1023\/A:1021918104127","article-title":"Valproate-induced hyperammonemic encephalopathy","volume":"17","author":"Verrotti","year":"2002","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.yebeh.2021.108220_b0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/15563650902752376","article-title":"Carnitine in the treatment of valproic acid-induced toxicity","volume":"47","author":"Lheureux","year":"2009","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.yebeh.2021.108220_b0095","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpeds.2016.02.080","article-title":"Clinical features of carnitine deficiency secondary to pivalate-conjugated antibiotic therapy","volume":"173","author":"Kobayashi","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.yebeh.2021.108220_b0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jiac.2019.07.013","article-title":"Hypoglycemia associated with pivalate-conjugated antibiotics in young children: A retrospective study using a medical and pharmacy claims database in Japan","volume":"26","author":"Tatebe","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.yebeh.2021.108220_b0105","first-page":"591","article-title":"Pancreatitis in children","volume":"37","author":"Werlin","year":"2003","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.yebeh.2021.108220_b0110","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1542\/peds.64.4.520","article-title":"Pancreatitis associated with Valproic acid therapy","volume":"64","author":"Batalden","year":"1979","journal-title":"Pediatrics"},{"key":"10.1016\/j.yebeh.2021.108220_b0115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1528-1157.1993.tb02395.x","article-title":"Valproate-associated pancreatitis","volume":"34","author":"Asconape","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108220_b0120","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1592\/phco.21.20.1549.34480","article-title":"Pancreatitis associated with valproic acid: a review of the literature","volume":"21","author":"Chapman","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.yebeh.2021.108220_b0125","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00005792-200207000-00006","article-title":"Fatal pancreatitis associated with valproic acid, review of the literature","volume":"81","author":"Yazdani","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.yebeh.2021.108220_b0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00535-006-1961-4","article-title":"Valproic acid-induced pancreatitis: 16 new cases and a review of the literature","volume":"42","author":"Gerstner","year":"2007","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.yebeh.2021.108220_b0135","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1542\/peds.2006-1182","article-title":"The spectrum of valproic acid-associated pancreatitis","volume":"118","author":"Werlin","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.yebeh.2021.108220_b0140","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ana.410110226","article-title":"Monitoring of serum amylase levels during valproic acid therapy","volume":"11","author":"Bale","year":"1982","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2021.108220_b0145","first-page":"217","article-title":"Side effects of sodium valproate, mainly related to its hepatic and pancreatic toxicity","volume":"6","author":"Jimenez-Rodriguezvila","year":"1986","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1016\/j.yebeh.2021.108220_b0150","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1016\/j.transproceed.2013.08.041","article-title":"L-carnitine protects against cyclosporine-induced pancreatic and renal injury in rats","volume":"45","author":"Xiang","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.yebeh.2021.108220_b0155","doi-asserted-by":"crossref","DOI":"10.9738\/INTSURG-D-16-00058.1","article-title":"The histopathologic effects of L-carnitine in sodium taurocholate induced severe pancreatitis model","author":"Karakahya","year":"2016","journal-title":"Int Surg"},{"key":"10.1016\/j.yebeh.2021.108220_b0160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1742-7843.2009.00399.x","article-title":"Acetyl-L-carnitine ameliorates caerulein-induced acute pancreatitis in rats","volume":"105","author":"Arafa","year":"2009","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.yebeh.2021.108220_b0165","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s10620-014-3461-3","article-title":"Investigation of protective effect of L-carnitine on L-asparaginase-induced acute pancreatic injury in male Balb\/c mice","volume":"60","author":"Kaya","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.yebeh.2021.108220_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/721871","article-title":"Acute pancreatitis with rapid clinical improvement in a child with isovaleric acidemia","volume":"2013","author":"Mantadakis","year":"2013","journal-title":"Case Rep Pediatr"},{"key":"10.1016\/j.yebeh.2021.108220_b0175","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1528-1167.2007.01429.x","article-title":"Valproate-induced thrombocytopenia: a prospective monotherapy study","volume":"49","author":"Nasreddine","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108220_b0180","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11239-020-02241-1","article-title":"Treatment of platelet concentrates with the L-carnitine modulates platelets oxidative stress and platelet apoptosis due to mitochondrial reactive oxygen species reduction and reducing cytochrome C release during storage","volume":"51","author":"Amiri","year":"2021","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.yebeh.2021.108220_b0185","doi-asserted-by":"crossref","first-page":"H41","DOI":"10.1152\/ajpheart.00249.2002","article-title":"Carnitine inhibits arachidonic acid turnover, platelet function, and oxidative stress","volume":"284","author":"Pignatelli","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021004819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021004819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:42:16Z","timestamp":1761504136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505021004819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":37,"alternative-id":["S1525505021004819"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.108220","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of l-carnitine supplementation in patients with childhood-onset epilepsy prescribed valproate","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.108220","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108220"}}